Mehiar El-Hamdani, MD
Cardiovascular Disease · Huntington, WVNPI 1932290939
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,753 of the $4,342 with a category attached, or 63.4%. It is spread thinly across 25 manufacturers, the largest accounting for just 17.3%. Reporting peaked in 2019 at $1,815 and has fallen 85.9% since, to $257 in 2025.
Across 115 payments — averaging $37.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$751
- Penumbra, Inc.$694
- Cook Incorporated$655
- Cook Medical LLC$601
- Abiomed$397
- Medtronic$225
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,59037%
- Food & beverage$2,75363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 14 | $751 |
| Penumbra, Inc. | 10 | $694 |
| Cook Incorporated | 2 | $655 |
| Cook Medical LLC | 7 | $601 |
| Abiomed | 7 | $397 |
| Medtronic(2 entities) | 25 | $225 |
| Johnson & Johnson(2 entities) | 9 | $184 |
| Novartis | 9 | $182 |
| W. L. Gore & Associates, Inc. | 1 | $83 |
| AstraZeneca | 4 | $75 |
| Boston Scientific | 3 | $70 |
| Pfizer | 4 | $61 |
| Angiodynamics, Inc. | 1 | $59 |
| Heartflow, Inc. | 1 | $53 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Bard Peripheral Vascular, Inc. | 3 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $28 |
| Osprey Medical Inc | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Cardiovascular Systems Inc. | 2 | $17 |
| Cvrx, Inc. | 1 | $15 |
| Inari Medical, Inc. | 1 | $15 |
| Celonova Biosciences, Inc. | 1 | $15 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,342 in reported general payments places this provider in the 60th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 124 | $163,667 |
| XareltoRivaroxaban | 25 | $34,309 |
| JardianceEmpagliflozin | 11 | $14,596 |
| Repatha SureclickEvolocumab | 21 | $13,287 |
| Enoxaparin Sodium | 51 | $12,573 |
| Praluent PenAlirocumab | 15 | $8,356 |
| Warfarin Sodium | 397 | $4,708 |
| Metoprolol Succinate | 278 | $3,061 |
| Ranolazine ErRanolazine | 38 | $2,214 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 183 | $2,022 |
| ClopidogrelClopidogrel Bisulfate | 177 | $1,975 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 69 | $1,677 |
| Atorvastatin Calcium | 152 | $1,275 |
| Spironolactone | 87 | $993 |
| Rosuvastatin Calcium | 93 | $892 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $61 | $163,667124 claims |
| Johnson & JohnsonXarelto | $184 | $34,30925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 100 cardiovascular disease providers in West Virginia.
Other cardiovascular disease in Huntington
- Kofi OseiHuntington$87K
- Esam BaryunHuntington$55K
- Rameez SayyedHuntington$21K
- Jason MaderHuntington$13K
- Samian SulaimanHuntington$7K
- Mark StudenyHuntington$7K
- Ellen ThompsonHuntington$6K
- Amrit ThakurHuntington$5K
- George LinsenmeyerHuntington$2K
- Sarah RinehartCharleston$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.